FDA Clinical Trial Guidances Share Biden Administration's Goals for Advancing Development of Cancer Treatments

SILVER SPRING, Md., March 1, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued three final guidances to industry regarding cancer clinical trials that parallel the goals of

Related Keywords

Richard Pazdur ,Oncology Center ,Us Department Of Health ,Human Services ,Drug Administration ,President Biden ,Cancer Moonshot ,Older Adults ,Cancer Clinical Trials ,First In Human Clinical Trials ,Expedite Development ,Oncology Drugs ,Efficient Clinical Trial Design Strategies ,Aprilm Grant ,National ,